Results 151 to 160 of about 73,565 (199)

Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025

Pigment Cell &Melanoma Research, Volume 39, Issue 4, July 2026.
ABSTRACT The 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting took place in Amsterdam, The Netherlands on October 25th, 2025. Several promising drug candidates are in development; however, there is still an urgent need for better prevention, detection, and treatment of uveal melanoma.
Andrew E. Aplin, Katherina Alsina, Allison S. Betof, Joseph Birkett, Marcus O. Butler, George Cole Jr., Rizwan Haq, Florian A. Karreth, Vinit B. Mahajan, Rahul Marpadga, Prithvi Mruthyunjaya, Paul Nathan, Jonas A. Nilsson, Gary Palmer, Joseph J. Sacco, Takami Sato, Sarah Stanhope, Pang‐ning Teng, Kyleigh LiPira   +18 more
wiley   +1 more source

Plant-Based Strategies for Vaccine Development: A Narrative Review of Recombinant Biofactories, Phytochemical Adjuvants, Innovative Delivery Systems, and Insights on Oral and Edible Vaccines. [PDF]

Vaccines (Basel)
Najafi K, Jojani M, Najafi S, Roviello GN.   +3 more
europepmc   +1 more source

The EBNA‐1 Conundrum: Does Epstein–Barr Virus Invoke Autoimmune Pathology in a Population Subset by Poorly Purine‐Loading Its Major Latency‐Maintaining Transcript?

Scandinavian Journal of Immunology, Volume 104, Issue 1, July 2026.
ABSTRACT Viruses activate host defences by alerting interferon and other alarms. Viruses seeking latency must curtail this. Infected subjects would then have minimal immune system activation and remain healthy. However, a minority cannot prevent emergence of associated diseases.
Donald R. Forsdyke
wiley   +1 more source

Structural studies promote vaccine development: lessons from African swine fever virus. [PDF]

Protein Cell
Zhang Y, Zhu L.
europepmc   +1 more source

Encapsulin‐Protected Immunotherapeutic Complexes: Bacteria‐Derived Nanoparticles for mRNA Delivery to Eukaryotic Cells

ChemMedChem, Volume 21, Issue 11, 15 June 2026.
Here, we introduce a biological, self‐assembling supramolecular nanoparticle designed to encapsulate eukaryotic‐expressible mRNA within an encapsulin shell via an encapsulin‐RNA adaptor peptide (ERAP). This process occurs in bacteria, and the resulting complex can deliver its mRNA into eukaryotic cells, where it is expressed.
Carlos Francisco Coffeen, Maribel Cayetano‐Cruz, Damaris Ilhuicatzi‐Alvarado, Carmen Méndez, Leticia Moreno‐Fierros, Ismael Bustos‐Jaimes   +5 more
wiley   +1 more source

Brucellosis vaccine development: immunological mechanisms, animal models, and future directions. [PDF]

Arch Microbiol
Zhang Y, Li D, Wang B, Li X, Qi Y, Ding H.   +5 more
europepmc   +1 more source

Immunopotentiation by Natural Extracts: Mechanisms and Applications in Influenza Vaccine Adjuvant Development. [PDF]

Food Sci Nutr
Ho TL, Ko EJ.
europepmc   +1 more source

A Rabies Virus Glycoprotein Subunit Vaccine Produced in <i>Pichia pastoris</i> Induces Neutralizing Antibodies in Mice. [PDF]

Vaccines (Basel)
Yang Y, Mo R, Hou Z, Wang H, Sun P, Liu R, Wang T, Zhang B, Hou X, Zhao Y, Wu J, Liu B.   +11 more
europepmc   +1 more source

A Modular Design of a Cholera Toxin B Subunit-Scaffolded Sub-Virion Nanoparticle Vaccine Against West Nile Virus. [PDF]

Microb Biotechnol
Byun H, Kim TH, Sung J, Lee JM, Shim SM, Kang SH, Kang H, Moon DH, Park SH, Kim D, Kim SJ, Kim S, Han G, Seong BL.   +13 more
europepmc   +1 more source

Advances and Translational Challenges in <i>Toxoplasma gondii</i> Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. [PDF]

Vet Sci
Qadeer A, Tharwat M, Khan MZ, Juhasz A, Alshanbari FA.   +4 more
europepmc   +1 more source